ArticleBMC pulmonary medicine2025
Pulmonary cavernous hemangioma: a case report.
Article in BMC pulmonary medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Case Report: Cardiac angioma with multiple pulmonary angiomatous nodules: a rare presentation of systemic angiomatosis.Frontiers in cardiovascular medicine · 2026Article
- Multiple Pulmonary Cavernous Hemangioma: A Case Report.Surgical case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCavernous hemangiomas can occur in various internal organs like the liver, kidney, bladder, and skin, or even in subcutaneous tissues. However, they rarely occur in the lungs, making pulmonary cavernous hemangiomas (PCH) an uncommon finding. Herein, we report a rare case of pulmonary cavernous hemangioma that was surgically resected. CASE PRESENTATION: A 16-year-old adolescent patient was diagnosed with a pulmonary cavernous hemangioma during a physical examination. During the entry physical examination, a chest X-ray showed shadows in the upper lobe of the right lung. The patient was admitted to the Thoracic Surgery Department for further assessment. The patient had a one-year history of smoking; however, he did not experience any clinical symptoms related to respiratory diseases. Among tumor markers assessed, only the cytokeratin-19 fragment (CYFRA21-1) was elevated. Chest computed tomography (CT) showed irregular soft tissue lesions in the upper lobe of the right lung. The lesion presented as a shallow lobe with clear boundaries, accompanied by the presence of spicules around it. The lesion showed mild to moderate uniform enhancement in the arterial phase and slightly reduced in the venous phase on imaging. The lesion was anatomically close to adjacent bronchus and blood vessels. In addition, the patient had multiple enlarged lymph nodes in the mediastinum. In summary, the thoracic surgeon could not rule out the possibility of lung malignant tumors and chose to proceed with surgical excision to secure a conclusive diagnosis. Post-operative histological examination showed that the lesion consisted of dilated nodular hyperplasia rich in red blood cells, leading to a diagnosis of PCH. No recurrence has been observed since postoperative follow-up. CASE PRESENTATION: We reported a rare PCH case, reviewed the clinical features, imaging findings, histopathological features, and treatment options of PCH based on relevant literature, and gained a further understanding of PCH.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.